Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(29%)
Results Posted
0%(0 trials)
Terminated
1(14%)

Phase Distribution

Ph phase_1
1
14%
Ph early_phase_1
1
14%
Ph not_applicable
3
43%
Ph phase_2
1
14%
Ph phase_4
1
14%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 41 (14.3%)
N/A3 (42.9%)

Trials by Status

terminated114%
completed457%
recruiting229%

Recent Activity

2 active trials
Showing 5 of 7
recruitingphase_4

Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences

NCT05997732
recruitingearly_phase_1

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

NCT05219799
completednot_applicable

Sex Differences in Sympathetic Vascular Reactivity at High Altitude

NCT05525416
terminatedphase_1

A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems

NCT03098680
completednot_applicable

Reversing the Effects of 2% Lidocaine

NCT02861378
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05997732Phase 4

Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences

Recruiting
NCT05219799Early Phase 1

Sex Disparities in Hypoxic Vasodilation and Impact of Obesity

Recruiting
NCT05525416Not Applicable

Sex Differences in Sympathetic Vascular Reactivity at High Altitude

Completed
NCT03098680Phase 1

A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems

Terminated
NCT02861378Not Applicable

Reversing the Effects of 2% Lidocaine

Completed
NCT00080808Phase 2

Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer

Completed
NCT00226096Not Applicable

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7